108 related articles for article (PubMed ID: 16424868)
1. Pro-apoptotic properties of hyperforin in leukemic cells from patients with B-cell chronic lymphocytic leukemia.
Quiney C; Billard C; Faussat AM; Salanoubat C; Ensaf A; Naït-Si Y; Fourneron JD; Kolb JP
Leukemia; 2006 Mar; 20(3):491-7. PubMed ID: 16424868
[TBL] [Abstract][Full Text] [Related]
2. 4-arylcoumarin analogues of combretastatins stimulate apoptosis of leukemic cells from chronic lymphocytic leukemia patients.
Billard C; Menasria F; Quiney C; Faussat AM; Finet JP; Combes S; Kolb JP
Exp Hematol; 2008 Dec; 36(12):1625-33. PubMed ID: 18922614
[TBL] [Abstract][Full Text] [Related]
3. Hyperforin induces apoptosis of chronic lymphocytic leukemia cells through upregulation of the BH3-only protein Noxa.
Zaher M; Tang R; Bombarda I; Merhi F; Bauvois B; Billard C
Int J Oncol; 2012 Jan; 40(1):269-76. PubMed ID: 21947285
[TBL] [Abstract][Full Text] [Related]
4. Hyperforin inhibits Akt1 kinase activity and promotes caspase-mediated apoptosis involving Bad and Noxa activation in human myeloid tumor cells.
Merhi F; Tang R; Piedfer M; Mathieu J; Bombarda I; Zaher M; Kolb JP; Billard C; Bauvois B
PLoS One; 2011; 6(10):e25963. PubMed ID: 21998731
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis in K562 cells by dicyclohexylammonium salt of hyperforin through a mitochondrial-related pathway.
Liu JY; Liu Z; Wang DM; Li MM; Wang SX; Wang R; Chen JP; Wang YF; Yang DP
Chem Biol Interact; 2011 Apr; 190(2-3):91-101. PubMed ID: 21376709
[TBL] [Abstract][Full Text] [Related]
6. Hyperforin inhibits MMP-9 secretion by B-CLL cells and microtubule formation by endothelial cells.
Quiney C; Billard C; Mirshahi P; Fourneron JD; Kolb JP
Leukemia; 2006 Apr; 20(4):583-9. PubMed ID: 16467866
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic insights into the antileukemic activity of hyperforin.
Billard C; Merhi F; Bauvois B
Curr Cancer Drug Targets; 2013 Jan; 13(1):1-10. PubMed ID: 22924417
[TBL] [Abstract][Full Text] [Related]
8. Flavopiridol downregulates the expression of both the inducible NO synthase and p27(kip1) in malignant cells from B-cell chronic lymphocytic leukemia.
Billard C; Kern C; Tang R; Ajchenbaum-Cymbalista F; Kolb JP
Leukemia; 2003 Dec; 17(12):2435-43. PubMed ID: 14523476
[TBL] [Abstract][Full Text] [Related]
9. The BH3-only protein Noxa is stimulated during apoptosis of chronic lymphocytic leukemia cells triggered by M2YN, a new plant-derived extract.
Zaher M; Mirshahi M; Nuraliev Y; Sharofova M; Bombarda I; Marie JP; Billard C
Int J Oncol; 2011 Oct; 39(4):965-72. PubMed ID: 21750864
[TBL] [Abstract][Full Text] [Related]
10. Fludarabine-induced apoptosis of B chronic lymphocytic leukemia cells includes early cleavage of p27kip1 by caspases.
Sanhes L; Tang R; Delmer A; DeCaprio JA; Ajchenbaum-Cymbalista F
Leukemia; 2003 Jun; 17(6):1104-11. PubMed ID: 12764376
[TBL] [Abstract][Full Text] [Related]
11. Flavopiridol-induced iNOS downregulation during apoptosis of chronic lymphocytic leukemia cells is caspase-dependent.
Billard C; Menasria F; Quiney C; Faussat AM; Kolb JP
Leuk Res; 2008 May; 32(5):755-60. PubMed ID: 17981326
[TBL] [Abstract][Full Text] [Related]
12. Hyperforin inhibits P-gp and BCRP activities in chronic lymphocytic leukaemia cells and myeloid cells.
Quiney C; Billard C; Faussat AM; Salanoubat C; Kolb JP
Leuk Lymphoma; 2007 Aug; 48(8):1587-99. PubMed ID: 17701591
[TBL] [Abstract][Full Text] [Related]
13. Noxa upregulation is associated with apoptosis of chronic lymphocytic leukemia cells induced by hyperforin but not flavopiridol.
Zaher M; Akrout I; Mirshahi M; Kolb JP; Billard C
Leukemia; 2009 Mar; 23(3):594-6. PubMed ID: 18784742
[No Abstract] [Full Text] [Related]
14. Promising anti-leukemic activity of atorvastatin.
Żołnierczyk JD; Borowiak A; Hikisz P; Cebula-Obrzut B; Błoński JZ; Smolewski P; Robak T; Kiliańska ZM
Oncol Rep; 2013 May; 29(5):2065-71. PubMed ID: 23440293
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosis.
Schempp CM; Kirkin V; Simon-Haarhaus B; Kersten A; Kiss J; Termeer CC; Gilb B; Kaufmann T; Borner C; Sleeman JP; Simon JC
Oncogene; 2002 Feb; 21(8):1242-50. PubMed ID: 11850844
[TBL] [Abstract][Full Text] [Related]
16. Post-transcriptional regulation of inducible nitric oxide synthase in chronic lymphocytic leukemia B cells in pro- and antiapoptotic culture conditions.
Tiscornia AC; Cayota A; Landoni AI; Brito C; Oppezzo P; Vuillier F; Robello C; Dighiero G; Gabús R; Pritsch O
Leukemia; 2004 Jan; 18(1):48-56. PubMed ID: 14574328
[TBL] [Abstract][Full Text] [Related]
17. Hyperforin, a new lead compound against the progression of cancer and leukemia?
Quiney C; Billard C; Salanoubat C; Fourneron JD; Kolb JP
Leukemia; 2006 Sep; 20(9):1519-25. PubMed ID: 16791262
[TBL] [Abstract][Full Text] [Related]
18. Cyclin-dependent kinase inhibitor Roscovitine induces apoptosis in chronic lymphocytic leukemia cells.
Hahntow IN; Schneller F; Oelsner M; Weick K; Ringshausen I; Fend F; Peschel C; Decker T
Leukemia; 2004 Apr; 18(4):747-55. PubMed ID: 14973497
[TBL] [Abstract][Full Text] [Related]
19. Involvement of CED-3/ICE proteases in the apoptosis of B-chronic lymphocytic leukemia cells.
Bellosillo B; Dalmau M; Colomer D; Gil J
Blood; 1997 May; 89(9):3378-84. PubMed ID: 9129045
[TBL] [Abstract][Full Text] [Related]
20. Apoptotic effects on B-cell chronic lymphocytic leukemia (B-CLL) cells of heterocyclic compounds isolated from Guttiferaes.
Menasria F; Azebaze AG; Billard C; Faussat AM; Nkengfack AE; Meyer M; Kolb JP
Leuk Res; 2008 Dec; 32(12):1914-26. PubMed ID: 18656257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]